Puerto Rico Pharma: Battered but Unbroken

One year after Hurricane Maria, Puerto Rico's pharma industry is standing its ground.

PM1809 WebLeadImage 295X269

Ask someone what it was like in Puerto Rico the night Hurricane Maria barreled into the island, and often, the answers take on a surprisingly calm tone. Sure, it was loud. The winds roared at over 155 miles per hour. And there was the sideways rain — something many had never seen. But although some stayed awake all night and watched as Maria showed no mercy, many managed to sleep. For most on the island, the real drama began the morning after. “It’s as if you went to sleep in the 21st century and woke up in the 19th century,” Marco Monrouzeau, CFO and general manager of Neolpharma, says as we sit in his office in Caguas. All throughout Puerto Rico, it looked as…

Full Story

Don't Miss These Pharma Manufacturing Exclusives


On-demand, concise audio and powerpoint tutorials on the fundamental concepts of pharmaceutical manufacturing, process development, quality control and compliance.

Research Zone

A collection of news stories highlighting advances in medical science and pharmaceutical R&D.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • Product Focus: Innovative Packaging Systems

    By Meagan Parrish, Senior Editor

    Like many areas of pharmaceutical manufacturing, packaging equipment has been undergoing changes. With the rise of personalized medicines and increased demand for smaller batch sizes, packaging systems vendors are more closely considering space, simplicity and flexibility in new…

    Full Story
  • Top 6 Misconceptions About Optimizing Pharma Facilities

    By Fred Woo, PE, Manager, Engineering, Optimum Energy

    Pharmaceutical manufacturing facilities are energy intensive, and the HVAC system — the chilled water plant, steam and hot water plant, and air distribution — typically consumes a full 65 percent of the energy used, according to research by Lawrence Berkeley National Laboratory.That is a strong…

    Full Story
  • Analyzing for Elemental Impurities

    By Nikki Schopp, Assistant Manager, Analytical Laboratory Services, SGS Life Sciences

    US Pharmacopeia General Chapter <231> Heavy Metals, which describes a wet chemistry procedure for the analysis of heavy metal elemental impurities in pharmaceuticals that was developed more than 100 years ago, has finally been updated as USP <232> and USP <233>. However, there is…

    Full Story
  • Unpacking the Complexity of Biologic Drug Containment

    By Susan M. Dounce, Principal SME — Prefilled Syringes, Crystal Zenith, and Combination Products, West Pharmaceutical Services

    The pace of biologic drug development, including the development of therapeutic proteins (especially antibodies) as well as gene and cell therapies, is accelerating. In 2017, 79 percent of approvals by the U.S. Food and Drug Administration of New Molecular Entities (NMEs) were biologic drugs and…

    Full Story
  • From the Editor: Rising Up

    By Karen Langhauser, Chief Content Director

    A brief pause for a selfie in Humacao During one of our interviews in Puerto Rico, we switch the recorder off, look across the table at the plant leaders we are interviewing and say, point blank, “I don’t think we should be denying the fact that the government failed this island in the…

    Full Story
  • 4 Cash-Saving Hacks for the Pharma Industry

    By Selwyn Stein, Managing Director, VAT IT

    It’s easy to turn a blind eye to the fact that your pharmaceutical company might be losing thousands of dollars every year in tax savings — savings that are actually rightfully yours.This is because the worlds of both domestic and foreign value-added tax (VAT) and tax recovery is intimidating.

    Full Story

Latest Products